NHS England cuts treatments from Cancer Drugs Fund After a second assessment of the Cancer Drugs Fund, NHS England has further reduced the list by 17 drugs for 23 different indications.…
FDA approves rolapitant to prevent chemotherapy-induced nausea The US Food and Drug Administration has approved rolapitant as part of a combination of drugs to prevent nausea and vomiting caused by certain types of cancer chemotherapy.…
Widespread prescribing of antipsychotics for intellectually disabled people revealed As many as 71% of adults with a learning disability were prescribed an antipsychotic when they had no record of any mental illness, a study reported in The BMJ has found.…
Don’t get too excited about ‘female Viagra’ FDA succumbs to pressure to approve first agent to treat hypoactive sexual desire disorder in women.…
Researchers boost hypertension treatment using unconventional approach Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.…
Actinic keratosis gel linked with allergic reactions and shingles Picato gel, used to treat actinic keratosis, has been linked with shingles, severe allergic reactions, eye injuries and skin reactions when used incorrectly, the FDA warns.…
Heart risks with newer hepatitis C drugs and amiodarone The EMA has warned against the use of antiarrhythmic amiodarone in combination with newer hepatitis C infection treatments after reports of heart problems.…
Breast cancer patients worry about effects of tamoxifen on fertility Tamoxifen has had a major impact on reducing the risk of breast cancer recurrences, but many younger women are either not starting treatment or are discontinuing it early.…
Oral contraceptives may improve inflammatory arthritis outcomes Taking oral contraceptives may benefit women who have inflammatory arthritis, according to research published in Arthritis Care and Research.…
First drug to improve sexual desire in women approved in the United States Addyi (flibanserin), a drug dubbed the ‘female Viagra’, has been approved for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women by the FDA.…